Micro Labs Limited — Azithromycin Exporter Profile
Indian Pharmaceutical Exporter · #3 for Azithromycin · $5.5M export value · DGFT Verified
Micro Labs Limited is the #3 Indian exporter of Azithromycin with $5.5M in export value and 110 verified shipments. Micro Labs Limited holds a 3.0% market share in Azithromycin exports across 17 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
Micro Labs Limited — Azithromycin Export Profile: Buyers & Destinations
Where Does Micro Labs Limited Export Azithromycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| IRAQ | $538.2K | 11 | 28.4% |
| TURKEY | $327.0K | 7 | 17.3% |
| JORDAN | $247.1K | 12 | 13.0% |
| SRI LANKA | $171.0K | 15 | 9.0% |
| MADAGASCAR | $132.8K | 32 | 7.0% |
| MALDIVES | $108.0K | 13 | 5.7% |
| MYANMAR | $108.0K | 18 | 5.7% |
| FRANCE | $98.8K | 14 | 5.2% |
| RUSSIA | $39.5K | 2 | 2.1% |
| UGANDA | $30.6K | 5 | 1.6% |
Micro Labs Limited exports Azithromycin to 17 countries. The largest destination is IRAQ accounting for 28.4% of Micro Labs Limited's Azithromycin shipments, followed by TURKEY (17.3%) and JORDAN (13.0%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Azithromycin from Micro Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AL-KAWKAB SCIENTIFIC BUREAU | JORDAN | $490.2K | 17 |
| HAWKARY PHARMACEUTICAL COMPANY# | IRAQ | $295.1K | 6 |
| HAWKARY PHARMACEUTICAL COMPANY | TURKEY | $277.0K | 6 |
| MICRO HEALTHCARE PRIVATE LIMITED | SRI LANKA | $95.1K | 7 |
| MYITTAR AHLINN YAUNG CO LTD | MYANMAR | $82.0K | 11 |
| MICRO HEALTHCARE (PRIVATE) LIMITED | SRI LANKA | $75.9K | 8 |
| E.P.DIS | FRANCE | $60.2K | 7 |
| LABOREX UGANDA LIMITED | KENYA | $54.8K | 8 |
| HAWKARY PHARMACEUTICAL CO | TURKEY | $50.0K | 1 |
| SOMAPHAR | MADAGASCAR | $42.1K | 11 |
Micro Labs Limited supplies Azithromycin to 40 buyers globally. The largest buyer is AL-KAWKAB SCIENTIFIC BUREAU (JORDAN), followed by HAWKARY PHARMACEUTICAL COMPANY# (IRAQ) and HAWKARY PHARMACEUTICAL COMPANY (TURKEY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Azithromycin Export Value and How Much Does Micro Labs Limited Contribute?
India exported $74.0M worth of Azithromycin through 15,000 shipments from 853 suppliers to 169 countries, serving 2,397 buyers globally. Micro Labs Limited contributes $5.5M to this total, accounting for 3.0% of India's Azithromycin exports. Micro Labs Limited ships Azithromycin to 17 countries through 40 buyers.
What Is the Average Shipment Value for Micro Labs Limited's Azithromycin Exports?
Micro Labs Limited's average Azithromycin shipment value is $50.0K per consignment, based on 110 shipments totaling $5.5M. The largest destination is IRAQ (28.4% of Micro Labs Limited's Azithromycin exports).
How Does Micro Labs Limited Compare to Other Indian Azithromycin Exporters?
Micro Labs Limited ranks #3 among 853 Indian Azithromycin exporters with a 3.0% market share. The top 3 exporters are LUPIN LIMITED ($11.0M), ALEMBIC PHARMACEUTICALS LIMITED ($8.7M), CIPLA LIMITED ($8.4M). Micro Labs Limited processed 110 shipments to 17 destination countries.
What Azithromycin Formulations Does Micro Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AZILIDE DRY SYRUP (AZITHROMYCIN FOR ORAL | $295.1K | 6 |
| AZILIDE 500 ( (Azithromycin 500mg Tablet | $138.6K | 12 |
| AZILIDE DRY SYRUP AZITHROMYCIN POWDER F | $100.0K | 2 |
| AZILIDE DRY SYRUP(AZITHROMYCIN POWDER FOR ORAL SUSPENSION 200MG/5ML)(30ML) QTY-97500.00PCS | $72.5K | 3 |
| AZILIDE DRY SYRUP(AZITHROMYCIN POWDER FOR ORAL SUSPENSION 200MG/5ML)(30ML)QTY-97100.000PCS | $72.1K | 3 |
| AZILIDE DRY SYRUP(AZITHROMYCIN POWDER FOR ORAL SUSPENSION 200MG/5ML)(30ML)(QTY-97080.00)PCS | $72.1K | 3 |
| AZILIDE DRY SYRUP AZITHROMYCIN POWDER FOR ORAL SUSPENSION 200MG/5ML X 30ML - TAX DOCUMENT NO:701207964 DT: 17.10.2023 | $50.0K | 1 |
| AZILIDE DRY SYRUP AZITHROMYCIN POWDER FOR ORAL SUSPENSION 200MG/5ML X 30ML - TAX DOCUMENT NO: 701207964 DT: 17.10.2023 | $50.0K | 1 |
| AZILIDE DRY SYRUP (AZITHROMYCIN FOR ORALSUSPENSION USP 200MG/5ML) (30ML) - TAXINVOICE NO: 701209085 DT: 26.07.2024 | $50.0K | 1 |
| AZILIDE DRY SYRUP (AZITHROMYCIN FOR ORALSUSPENSION USP 200MG/5ML) (30ML) - TAXINVOICE NO: 701209084 DT: 26.07.2024 | $50.0K | 1 |
Micro Labs Limited exports 107 distinct Azithromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AZILIDE DRY SYRUP (AZITHROMYCIN FOR ORAL with 6 shipments worth $295.1K.
How Does Micro Labs Limited Compare to Nearest Azithromycin Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | ZYDUS LIFESCIENCES LIMITED | $6.0M | 161 | 8 | $37.3K |
| 8 | AJANTA PHARMA LIMITED | $5.8M | 278 | 20 | $21.0K |
| 3 | MICRO LABS LIMITED ★ | $5.5M | 110 | 17 | $50.0K |
| 1 | LINCOLN PHARMACEUTICALS LTD | $4.8M | 97 | 16 | $50.0K |
| 10 | MACLEODS PHARMACEUTICALS LTD | $4.5M | 91 | 14 | $50.0K |
Micro Labs Limited ranks #3 among 853 Indian Azithromycin exporters. Average shipment value of $50.0K compared to the market average of $86.8K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and AJANTA PHARMA LIMITED.
Which Indian Ports Ship Azithromycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,394 | 16.0% |
| SAHAR AIR | 2,211 | 14.7% |
| DELHI AIR CARGO ACC (INDEL4) | 1,693 | 11.3% |
| DELHI AIR | 1,106 | 7.4% |
| JNPT/ NHAVA SHEVA SEA | 902 | 6.0% |
| NHAVA SHEVA SEA (INNSA1) | 870 | 5.8% |
| Bombay Air | 618 | 4.1% |
| JNPT | 408 | 2.7% |
What Other Antibiotics Products Does Micro Labs Limited Export?
Micro Labs Limited also exports these antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Micro Labs Limited's Azithromycin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Micro Labs Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
About Micro Labs Limited
Micro Labs Limited exports 76 products worth $463.6M. Beyond Azithromycin, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Azithromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Azithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 145 individual customs records matching Micro Labs Limited exporting Azithromycin, covering 107 formulations to 17 countries via 40 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 169+ countries, 2,397+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Azithromycin Export Data from Micro Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Azithromycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Azithromycin Stats
Company Overview
Top Products by Micro Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Azithromycin. For current shipment-level data, contact TransData Nexus.